RxDoctor Payments Data

Syed Husain, DPM

Podiatrist · Arlington Heights, ILNPI 1821182361

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $62,065 of the $82,135 with a category attached, or 75.6%. Acera Surgical, Inc. accounts for 76.9% of it on its own, with 40 other manufacturers making up the rest. Reporting peaked in 2020 at $41,167 and has fallen 97.0% since, to $1,253 in 2025. Among podiatrist clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$82,135in general payments, 2019–2025

Across 246 payments — averaging $333.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acera Surgical, Inc.$63K
  • Kerecis Limited$8K
  • Melinta Therapeutics, LLC$4K
  • Stryker$1K
  • Smith+Nephew$1K
  • Organogenesis Inc.$1K
  • plus $3K from 35 others
$165,646in research payments, 2019–2025

Across 2 payments — averaging $82,823 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Acera Surgical, Inc.$166K

What the payments were for

  • Consulting fees$62,06576%
  • Speaking & faculty fees$3,9395%
  • Travel & lodging$6,5878%
  • Food & beverage$7,0679%
  • Education$2,2583%
  • Entertainment$2180%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$82,135 in reported general payments places this provider in the 95th percentile of 409 podiatrist providers in Illinois.

See all podiatrist providers in Illinois

Medicare billing

Part B allowed, 2024
$286,127
Medicare patients
335
Services billed
1,551

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Linezolid11$400
Doxycycline Hyclate34$262
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen25$138
Meloxicam16$23

Paid to pharmacies, not to this prescriber.

Other podiatrist in Arlington Heights

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →